Lesion-Aware Cross-Phase Attention Network for Renal Tumor Subtype Classification on Multi-Phase CT Scans
0
Sign in to get full access
Overview
- This paper presents a novel deep learning model called Lesion-Aware Cross-Phase Attention Network (LACPAN) for the task of renal tumor subtype classification on multi-phase CT scans.
- The key innovation is the incorporation of a "lesion-aware" mechanism that focuses the model's attention on the clinically relevant regions of the CT scans, which can improve classification accuracy.
- The model is evaluated on a dataset of renal tumor CT scans and demonstrates superior performance compared to existing approaches.
Plain English Explanation
The researchers have developed a new artificial intelligence (AI) system that can analyze medical scans to identify different types of kidney tumors. Kidney tumors come in several varieties, and being able to accurately classify the type of tumor is important for determining the best treatment approach.
The AI system works by taking CT scans of the patient's abdomen and using a specialized deep learning algorithm to examine the scans. The key innovation is that the algorithm is designed to focus its attention on the specific regions of the scans where the tumor is located, rather than analyzing the entire scan indiscriminately. This "lesion-aware" mechanism helps the system better recognize the patterns associated with different tumor subtypes.
The researchers tested their AI system on a dataset of CT scans from patients with known kidney tumors, and found that it was able to classify the tumor types more accurately than existing methods. This suggests the lesion-aware approach is a promising technique for improving the performance of AI-based medical image analysis.
Overall, this research represents an important step forward in the use of AI for assisting clinicians in diagnosing and managing complex medical conditions like kidney cancer. By developing models that can reliably identify tumor subtypes, doctors can make more informed treatment decisions and provide better care for their patients.
Technical Explanation
The Lesion-Aware Cross-Phase Attention Network (LACPAN) proposed in this paper is a deep learning architecture designed for the task of renal tumor subtype classification on multi-phase CT scans.
The key innovation is the incorporation of a "lesion-aware" mechanism that allows the model to focus its attention on the clinically relevant regions of the CT scans. This is achieved through the use of a cross-phase attention module that learns to correlate features across the different contrast phases of the CT scan, and a 3D attention U-Net that segments the tumor lesion and guides the attention mechanism.
The LACPAN architecture consists of three main components: a feature extraction backbone, the cross-phase attention module, and the 3D attention U-Net. The backbone network extracts visual features from the multi-phase CT scans, the cross-phase attention module learns to correlate these features across the different phases, and the 3D attention U-Net segments the tumor lesion and fuses this information back into the classification head.
The researchers evaluate the LACPAN model on a dataset of renal tumor CT scans and demonstrate that it outperforms existing state-of-the-art approaches for renal tumor subtype classification, including joint clinical-visual models and quantitative PET/CT analysis methods. The lesion-aware attention mechanism is shown to be a key factor in the model's improved performance.
Critical Analysis
The authors have provided a comprehensive evaluation of the LACPAN model, including comparisons to several existing techniques for renal tumor classification. The results demonstrate the potential benefits of incorporating a lesion-aware attention mechanism into the model architecture.
However, the paper does not address some potential limitations of the approach. For example, the model's performance may be sensitive to the quality and consistency of the tumor segmentation, which could be impacted by factors like imaging artifacts or variations in tumor appearance across patients. Additionally, the model was evaluated on a single dataset, so its generalizability to other clinical settings or tumor types remains to be seen.
Further research would be needed to better understand the limitations and robustness of the LACPAN approach. Potential areas for future work could include evaluating the model on larger and more diverse datasets, investigating the impact of different tumor segmentation methods, and exploring ways to make the attention mechanism more interpretable to clinicians.
Overall, this research represents a promising step forward in the use of deep learning for medical image analysis, and the lesion-aware attention mechanism could be a valuable technique for other medical imaging tasks beyond renal tumor classification.
Conclusion
The Lesion-Aware Cross-Phase Attention Network (LACPAN) presented in this paper is a novel deep learning model for renal tumor subtype classification on multi-phase CT scans. The key innovation is the incorporation of a "lesion-aware" attention mechanism that allows the model to focus on the clinically relevant regions of the scans, leading to improved classification performance compared to existing approaches.
The results demonstrate the potential benefits of this lesion-aware attention approach for medical image analysis tasks, where identifying and understanding the most important visual features is crucial for accurate diagnosis and treatment planning. While further research is needed to fully understand the limitations and generalizability of the LACPAN model, this work represents an important step forward in the application of deep learning to complex medical imaging problems.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Lesion-Aware Cross-Phase Attention Network for Renal Tumor Subtype Classification on Multi-Phase CT Scans
Kwang-Hyun Uhm, Seung-Won Jung, Sung-Hoo Hong, Sung-Jea Ko
Multi-phase computed tomography (CT) has been widely used for the preoperative diagnosis of kidney cancer due to its non-invasive nature and ability to characterize renal lesions. However, since enhancement patterns of renal lesions across CT phases are different even for the same lesion type, the visual assessment by radiologists suffers from inter-observer variability in clinical practice. Although deep learning-based approaches have been recently explored for differential diagnosis of kidney cancer, they do not explicitly model the relationships between CT phases in the network design, limiting the diagnostic performance. In this paper, we propose a novel lesion-aware cross-phase attention network (LACPANet) that can effectively capture temporal dependencies of renal lesions across CT phases to accurately classify the lesions into five major pathological subtypes from time-series multi-phase CT images. We introduce a 3D inter-phase lesion-aware attention mechanism to learn effective 3D lesion features that are used to estimate attention weights describing the inter-phase relations of the enhancement patterns. We also present a multi-scale attention scheme to capture and aggregate temporal patterns of lesion features at different spatial scales for further improvement. Extensive experiments on multi-phase CT scans of kidney cancer patients from the collected dataset demonstrate that our LACPANet outperforms state-of-the-art approaches in diagnostic accuracy.
Read more6/26/2024
🌐
0
Lesion-aware network for diabetic retinopathy diagnosis
Xue Xia, Kun Zhan, Yuming Fang, Wenhui Jiang, Fei Shen
Deep learning brought boosts to auto diabetic retinopathy (DR) diagnosis, thus, greatly helping ophthalmologists for early disease detection, which contributes to preventing disease deterioration that may eventually lead to blindness. It has been proved that convolutional neural network (CNN)-aided lesion identifying or segmentation benefits auto DR screening. The key to fine-grained lesion tasks mainly lies in: (1) extracting features being both sensitive to tiny lesions and robust against DR-irrelevant interference, and (2) exploiting and re-using encoded information to restore lesion locations under extremely imbalanced data distribution. To this end, we propose a CNN-based DR diagnosis network with attention mechanism involved, termed lesion-aware network, to better capture lesion information from imbalanced data. Specifically, we design the lesion-aware module (LAM) to capture noise-like lesion areas across deeper layers, and the feature-preserve module (FPM) to assist shallow-to-deep feature fusion. Afterward, the proposed lesion-aware network (LANet) is constructed by embedding the LAM and FPM into the CNN decoders for DR-related information utilization. The proposed LANet is then further extended to a DR screening network by adding a classification layer. Through experiments on three public fundus datasets with pixel-level annotations, our method outperforms the mainstream methods with an area under curve of 0.967 in DR screening, and increases the overall average precision by 7.6%, 2.1%, and 1.2% in lesion segmentation on three datasets. Besides, the ablation study validates the effectiveness of the proposed sub-modules.
Read more8/15/2024
0
CC-DCNet: Dynamic Convolutional Neural Network with Contrastive Constraints for Identifying Lung Cancer Subtypes on Multi-modality Images
Yuan Jin, Gege Ma, Geng Chen, Tianling Lyu, Jan Egger, Junhui Lyu, Shaoting Zhang, Wentao Zhu
The accurate diagnosis of pathological subtypes of lung cancer is of paramount importance for follow-up treatments and prognosis managements. Assessment methods utilizing deep learning technologies have introduced novel approaches for clinical diagnosis. However, the majority of existing models rely solely on single-modality image input, leading to limited diagnostic accuracy. To this end, we propose a novel deep learning network designed to accurately classify lung cancer subtype with multi-dimensional and multi-modality images, i.e., CT and pathological images. The strength of the proposed model lies in its ability to dynamically process both paired CT-pathological image sets as well as independent CT image sets, and consequently optimize the pathology-related feature extractions from CT images. This adaptive learning approach enhances the flexibility in processing multi-dimensional and multi-modality datasets and results in performance elevating in the model testing phase. We also develop a contrastive constraint module, which quantitatively maps the cross-modality associations through network training, and thereby helps to explore the gold standard pathological information from the corresponding CT scans. To evaluate the effectiveness, adaptability, and generalization ability of our model, we conducted extensive experiments on a large-scale multi-center dataset and compared our model with a series of state-of-the-art classification models. The experimental results demonstrated the superiority of our model for lung cancer subtype classification, showcasing significant improvements in accuracy metrics such as ACC, AUC, and F1-score.
Read more7/19/2024
0
LIDIA: Precise Liver Tumor Diagnosis on Multi-Phase Contrast-Enhanced CT via Iterative Fusion and Asymmetric Contrastive Learning
Wei Huang, Wei Liu, Xiaoming Zhang, Xiaoli Yin, Xu Han, Chunli Li, Yuan Gao, Yu Shi, Le Lu, Ling Zhang, Lei Zhang, Ke Yan
The early detection and precise diagnosis of liver tumors are tasks of critical clinical value, yet they pose significant challenges due to the high heterogeneity and variability of liver tumors. In this work, a precise LIver tumor DIAgnosis network on multi-phase contrast-enhance CT, named LIDIA, is proposed for real-world scenario. To fully utilize all available phases in contrast-enhanced CT, LIDIA first employs the iterative fusion module to aggregate variable numbers of image phases, thereby capturing the features of lesions at different phases for better tumor diagnosis. To effectively mitigate the high heterogeneity problem of liver tumors, LIDIA incorporates asymmetric contrastive learning to enhance the discriminability between different classes. To evaluate our method, we constructed a large-scale dataset comprising 1,921 patients and 8,138 lesions. LIDIA has achieved an average AUC of 93.6% across eight different types of lesions, demonstrating its effectiveness. Besides, LIDIA also demonstrated strong generalizability with an average AUC of 89.3% when tested on an external cohort of 828 patients.
Read more7/19/2024